MichaelSBaumMD

PubMed

• 36 citations
  Hypertension among patients with renal cell carcinoma receiving axitinib or sorafenib: analysis from the randomized phase III AXIS trial
  Brian I. Rini, David I. Quinn, Michael S. Baum, Laura S. Wood, Jamal Tarazi, Brad Rosbrook, Lillian Shahied Arruda, Laura Cisar, W. Gregory Roberts, Sinil Kim, Robert ...> ;Targeted Oncology. 2015 Mar 1
• 7 citations
  Cardiac metastases from head and neck cancer mimicking a myocardial infarction.
  Nandini U. Yadav, Dipti Gupta, Michael S. Baum, Nancy Roistacher, Richard M. Steingart> ;Journal of Oral and Maxillofacial Surgery. 2014 Aug 1
• 96 citations
  Phase 1 trial of everolimus plus sunitinib in patients with metastatic renal cell carcinoma
  Ana M. Molina, Darren R. Feldman, Martin H. Voss, Michelle S. Ginsberg, Michael S. Baum, Dion R. Brocks, Patricia Fischer, M. J. Trinos, Sujata Patil, Robert J. Motzer> ;Cancer. 2012 Apr 1
• 74 citations
  Phase II trial of sunitinib in patients with metastatic non-clear cell renal cell carcinoma
  Ana M. Molina, Darren R. Feldman, Michelle S. Ginsberg, Glenn S. Kroog, Satish K. Tickoo, Xiaoyu Jia, Murielle Georges, Sujata Patil, Michael S. Baum, Victor E. Reuter...> ;Investigational New Drugs. 2012 Feb 1
• A phase II study of VEGF trap in patients with radioactive iodine (RAI)-refractory thyroid carcinoma.
  Sherman EJ, Ho AL, Haque S, Tuttle RM, Ghossein RA, Schöder H, Baum MS, Kelly K, Chen AP, Shaha AR, Pfister DG> ;J. Clin. Oncol.. 2011-05-20
• 462 citations
  Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib
  Brian I. Rini, Darrel P. Cohen, Dongrui R. Lu, Isan Chen, Subramanian Hariharan, Martin Gore, Robert A. Figlin, Michael S. Baum, Robert J. Motzer> ;Journal of the National Cancer Institute. 2011 May 4
• Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial.
  Cuzick J, Sestak I, Baum M, Buzdar A, Howell A, Dowsett M, Forbes JF> ;Lancet Oncol.. 2010-12-01
• Breast cancer awareness month. Still awaiting screening facts.
  Baum M, Thornton H, Gøtzsche PC, Bewley S, Jørgensen KJ, Barratt A, Ross N, Woloshin S, Schwartz L, Musiello T, Blennerhassett M, Napoli M, Baines CJ, Vaidya JS, Willi...> ;BMJ. 2010-11-02
• Response to "Intraoperative radiotherapy in early-stage breast cancer: results of the Montpellier phase II trial."(Int J Radiat Oncol Biol Phys May 2009).
  Vaidya JS, Tobias JS, Baum M, Keshtgar M, Williams N, Wenz F, Joseph D> ;Int. J. Radiat. Oncol. Biol. Phys.. 2010-07-15
• Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority ph...
  Vaidya JS, Joseph DJ, Tobias JS, Bulsara M, Wenz F, Saunders C, Alvarado M, Flyger HL, Massarut S, Eiermann W, Keshtgar M, Dewar J, Kraus-Tiefenbacher U, Sütterlin M, ...> ;Lancet. 2010-07-10
• Safety and efficacy of targeted intraoperative radiotherapy (TARGIT) for early breast cancer: First report of a randomized controlled trial at 10-years maximum follow-up.
  Baum M, Joseph DJ, Tobias JS, Wenz FK, Keshtgar MR, Alvarado M, Bulsara M, Eiermann W, Williams NR, Vaidya JS> ;J. Clin. Oncol.. 2010-06-20
• Prediction of risk of distant recurrence using the 21-gene recurrence score in node-negative and node-positive postmenopausal patients with breast cancer treated with ...
  Dowsett M, Cuzick J, Wale C, Forbes J, Mallon EA, Salter J, Quinn E, Dunbier A, Baum M, Buzdar A, Howell A, Bugarini R, Baehner FL, Shak S> ;J. Clin. Oncol.. 2010-04-10
• Surgery triggers outgrowth of latent distant disease in breast cancer: an inconvenient truth?
  Retsky M, Demicheli R, Hrushesky W, Baum M, Gukas I> ;Cancers (Basel). 2010-03-30
• 20 citations
  Phase I/II trial of sunitinib plus gefitinib in patients with metastatic renal cell carcinoma.
  Robert J. Motzer, Gary R. Hudes, Michelle S. Ginsberg, Michael S. Baum, Charles S. Harmon, Sindy T. Kim, Isan Chen, Bruce G. Redman> ;American Journal of Clinical Oncology. 2010 Dec 1
• Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen.
  Dowsett M, Cuzick J, Ingle J, Coates A, Forbes J, Bliss J, Buyse M, Baum M, Buzdar A, Colleoni M, Coombes C, Snowdon C, Gnant M, Jakesz R, Kaufmann M, Boccardo F, Godw...> ;J. Clin. Oncol.. 2010-01-20
• A new approach to treating breast cancer combining tumor removal and intraoperative radiotherapy: is it viable?
  Keshtgar M, Baum M> ;Womens Health (Lond Engl). 2010-01-01
• Phase II study of depsipeptide (DEP) in radioiodine (RAI)-refractory metastatic nonmedullary thyroid carcinoma.
  Sherman EJ, Fury MG, Tuttle RM, Ghossein R, Stambuk H, Baum M, Lisa D, Su YB, Shaha A, Pfister DG> ;J. Clin. Oncol.. 2009-05-20
• 241 citations
  Phase I Trial of Bevacizumab Plus Escalated Doses of Sunitinib in Patients With Metastatic Renal Cell Carcinoma
  Darren R. Feldman, Michael Baum, Michelle S. Ginsberg, Hani Hassoun, Carlos D. Flombaum, Susanne Velasco, Patricia Fischer, Ellen A. Ronnen, Nicole Ishill, Sujata Pati...> ;Journal of Clinical Oncology. 2009 Mar 20
• Tissue screening after breast reduction.
  Keshtgar M, Hamidian Jahromi A, Davidson T, Escobar P, Mallucci P, Mosahebi A, Baum M> ;BMJ. 2009-03-10
• Long-term effectiveness of adjuvant goserelin in premenopausal women with early breast cancer.
  Hackshaw A, Baum M, Fornander T, Nordenskjold B, Nicolucci A, Monson K, Forsyth S, Reczko K, Johansson U, Fohlin H, Valentini M, Sainsbury R> ;J. Natl. Cancer Inst.. 2009-03-04
• Flawed inferences about screening mammography's benefit based on observational data.
  Berry DA, Baines CJ, Baum M, Dickersin K, Fletcher SW, Gøtzsche PC, Jørgensen KJ, Junod B, Maehlen J, Schwartz LM, Welch HG, Woloshin S, Thornton H, Zahl P> ;J. Clin. Oncol.. 2009-02-01
• A lower incidence of gynecologic adverse events and interventions with anastrozole than with tamoxifen in the ATAC trial.
  Duffy SR, Distler W, Howell A, Cuzick J, Baum M> ;Am. J. Obstet. Gynecol.. 2009-01-01
• The effects of surgery on tumor growth: a century of investigations.
  Demicheli R, Retsky MW, Hrushesky WJM, Baum M, Gukas ID> ;Ann. Oncol.. 2008-11-01
• Targeted intra-operative radiotherapy-TARGIT for early breast cancer.
  Baum M, Vaidya JS> ;Ann. N. Y. Acad. Sci.. 2008-09-01
• 30 citations
  Capecitabine-induced coronary vasospasm.
  Yuliya B. Goldsmith, Nancy Roistacher, Michael S. Baum> ;Journal of Clinical Oncology. 2008 Aug 1
• Join now to see all